Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required)
This grant opportunity aims to support a multi-center consortium to form a clinical trials network focused on older adults with chronic pain conditions. The funding mechanism is phased into UG3 and UH3 stages. The UG3 phase, lasting up to 2 years, involves initial studies in healthy older adults to assess the safety and effects of psychedelic agents, which include substances like psilocybin, L…
The purpose of this funding opportunity is to support a multi-center consortium that will function as a clinical trials network to collect safety and early efficacy data in defined groups of older adults with specific chronic pain conditions. This funding opportunity will use a UG3/UH3 phased in…
Funding Source
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers